Create your page here
back to playlist
- Loading...
-
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer -
**Video Chart** -- $ADXS Advaxis Inc
**Video Chart** -- $ADXS Advaxis Inc**Video Chart** -- $ADXS Advaxis Inc
This is a video chart analysis of Advaxis (ADXS) as of April 12th, 2015 -
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
Advaxis, Inc. (ADXS.OB) Annotated Stock ChartAdvaxis, Inc. (ADXS.OB) Annotated Stock Chart
After a climb from 10 cents that reached a peak at nearly 20 cents, the ADXS chart has retraced, but is establishing a new higher low. Tuesday was a strong v... -
Adaxis's Trojan Horse Technology™
Adaxis's Trojan Horse Technology™Adaxis's Trojan Horse Technology™
Advaxis is developing multiple cancer immunotherapies based on our proprietary platform intended to teach the immune system to kill cancer and extend survival. Our researchers are studying the effect of using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), to actively suppress key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack. Our goal is to create a standard of care that is more effective and more tolerable than traditional chemotherapy or radiation. Watch our short video to learn more about the science behind the investigational therapies we are stud -
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to WatchADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
4/14/15 - https://www.thetechtrader.com - Even though the markets were mixed on Tuesday, a lot of our stocks continue to mow ahead. We have a lot of those stocks to cover here. Advaxis, Inc. (ADXS) has tripled, going from the low of 6.95 to over 22.00 on Tuesday in just a couple months. It looks like it doesn’t have any momentum lost at this point. It was up 1.19 to 21.78, or 5.78%, on 21 million shares. It may blow through the upper-channel line at some point, running up to the high 20’s, low 30’s, but for now, just keep raising your stops. It’s had five consecutive lower highs, along with some higher highs, so, as a result, it may continue -
Advaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis receives 2012 VIE award for best therapeutic vaccineAdvaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis ADXS-HPV is selected as the "Best Therapeutic Vaccine" at the 2012 World Vaccine Congress in Washington DC. Judges comments and Acceptance by Dr. Joh... -
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
-
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.comACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
9/15/15 - www.TheTechTrader.com - It was a very good day on Wall Street on Tuesday. The markets rallied all day, and in the last hour they pulled back a little bit, but not much. I like the way they closed. I like the way a lot of our stocks acted. So, let’s take a look at some old ones and some new ones Aceto Corp. (ACET), which we mentioned over the weekend, had an inside day on Monday, and on Tuesday it popped 1.70 to 28.87, or 6%, on nearly a half million shares, reaching as high as 29.82. This stock has a long uptrend from a low of 4.50-5.00 back in 2011, and is now up in the high 20’s. Looking at the overall picture, these are all-time -
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Advaxis CFFO Off 152%- Global Financial News Minute with Donald BaillargeonAdvaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Cash Flow from Operations for Advaxis, Inc. for its quarter ended January 31st was minus $2.1 million, a 152% deterioration over the year earlier same quarte... -
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.comADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
03/31/15 - http//www.TheTechTrader.com - The markets did not have a good day on this turnaround Tuesday. A lot of our stocks did well, so let’s go over a few old ones and new ones. Advaxis, Inc. (ADXS) impressed me by jumping a dollar. It didn’t hold the high, but it got up to a penny off the high at 15. It backed off about 50 cents and closed at 14.44, up 1.00, or 7 1/2%, on 1.86 million shares. That’s the best volume on an up day in a couple weeks. If it could just get a follow-through, we could see 18 or 19 on this stock. Capnia, Inc. (CAPN) popped on Tuesday, up 34 cents to 6.40, or 5.6%, on 7.8 million shares. It went up to 6.95, but c -
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
Soaring Immunotherapy Interest Pushing Advaxis Shares HigherSoaring Immunotherapy Interest Pushing Advaxis Shares Higher
Advaxis has seen its shares surge higher in the past month due to increased institutional interest and an optimistic response from investors to its 2015 outlook, said the company's CEO Dan O'Connor. O'Connor added that Boston's Adage Capital and T. Rowe Price are the large players that have taken significant positions in Advaxis. He said Advaxis has partnerships with Merck and MedImmune to explore their immunotherapy technology in combination with other agents and is seeking additional partners. O'Connor said he expects to start a Phase 3 trial for its cervical cancer therapy in the first half of 2015. Finally, he said the company has raised -
Advaxis: CEO Dan O'Connor
Advaxis: CEO Dan O'ConnorAdvaxis: CEO Dan O'Connor
Dan O'Connor, President and CEO of Advaxis, discusses his company's near term and long term goals. -
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancerFox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Drs. Marc Siegel and David Samadi discuss Advaxis's cancer immunotherapy as a potential treatment for a range of cancer indications, including breast, prostate, osteosarcoma, and head and neck, due to its potential to trigger the immune system to directly attack cancer cells. -
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoiceAdvaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Tom Moore, Chairman and CEO of Advaxis, discusses the company's business model, immunotherapy pipeline, targeted markets, and recent developments. The interv...
-
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical CancerSNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
SNNLive spoke with Thomas Moore, Chairman and CEO of Advaxis, Inc. (ADXS:OTCBB) at the 2013 Biotech, Healthcare, Life Science Week in San Francisco, CA. For ... -
**Video Chart** -- $ADXS Advaxis Inc
**Video Chart** -- $ADXS Advaxis Inc**Video Chart** -- $ADXS Advaxis Inc
This is a video chart analysis of Advaxis (ADXS) as of April 12th, 2015 -
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
Advaxis, Inc. (ADXS.OB) Annotated Stock ChartAdvaxis, Inc. (ADXS.OB) Annotated Stock Chart
After a climb from 10 cents that reached a peak at nearly 20 cents, the ADXS chart has retraced, but is establishing a new higher low. Tuesday was a strong v... -
Adaxis's Trojan Horse Technology™
Adaxis's Trojan Horse Technology™Adaxis's Trojan Horse Technology™
Advaxis is developing multiple cancer immunotherapies based on our proprietary platform intended to teach the immune system to kill cancer and extend survival. Our researchers are studying the effect of using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), to actively suppress key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack. Our goal is to create a standard of care that is more effective and more tolerable than traditional chemotherapy or radiation. Watch our short video to learn more about the science behind the investigational therapies we are stud -
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to WatchADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
4/14/15 - https://www.thetechtrader.com - Even though the markets were mixed on Tuesday, a lot of our stocks continue to mow ahead. We have a lot of those stocks to cover here. Advaxis, Inc. (ADXS) has tripled, going from the low of 6.95 to over 22.00 on Tuesday in just a couple months. It looks like it doesn’t have any momentum lost at this point. It was up 1.19 to 21.78, or 5.78%, on 21 million shares. It may blow through the upper-channel line at some point, running up to the high 20’s, low 30’s, but for now, just keep raising your stops. It’s had five consecutive lower highs, along with some higher highs, so, as a result, it may continue -
Advaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis receives 2012 VIE award for best therapeutic vaccineAdvaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis ADXS-HPV is selected as the "Best Therapeutic Vaccine" at the 2012 World Vaccine Congress in Washington DC. Judges comments and Acceptance by Dr. Joh... -
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
-
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.comACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
9/15/15 - www.TheTechTrader.com - It was a very good day on Wall Street on Tuesday. The markets rallied all day, and in the last hour they pulled back a little bit, but not much. I like the way they closed. I like the way a lot of our stocks acted. So, let’s take a look at some old ones and some new ones Aceto Corp. (ACET), which we mentioned over the weekend, had an inside day on Monday, and on Tuesday it popped 1.70 to 28.87, or 6%, on nearly a half million shares, reaching as high as 29.82. This stock has a long uptrend from a low of 4.50-5.00 back in 2011, and is now up in the high 20’s. Looking at the overall picture, these are all-time -
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Advaxis CFFO Off 152%- Global Financial News Minute with Donald BaillargeonAdvaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Cash Flow from Operations for Advaxis, Inc. for its quarter ended January 31st was minus $2.1 million, a 152% deterioration over the year earlier same quarte... -
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.comADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
03/31/15 - http//www.TheTechTrader.com - The markets did not have a good day on this turnaround Tuesday. A lot of our stocks did well, so let’s go over a few old ones and new ones. Advaxis, Inc. (ADXS) impressed me by jumping a dollar. It didn’t hold the high, but it got up to a penny off the high at 15. It backed off about 50 cents and closed at 14.44, up 1.00, or 7 1/2%, on 1.86 million shares. That’s the best volume on an up day in a couple weeks. If it could just get a follow-through, we could see 18 or 19 on this stock. Capnia, Inc. (CAPN) popped on Tuesday, up 34 cents to 6.40, or 5.6%, on 7.8 million shares. It went up to 6.95, but c -
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
Soaring Immunotherapy Interest Pushing Advaxis Shares HigherSoaring Immunotherapy Interest Pushing Advaxis Shares Higher
Advaxis has seen its shares surge higher in the past month due to increased institutional interest and an optimistic response from investors to its 2015 outlook, said the company's CEO Dan O'Connor. O'Connor added that Boston's Adage Capital and T. Rowe Price are the large players that have taken significant positions in Advaxis. He said Advaxis has partnerships with Merck and MedImmune to explore their immunotherapy technology in combination with other agents and is seeking additional partners. O'Connor said he expects to start a Phase 3 trial for its cervical cancer therapy in the first half of 2015. Finally, he said the company has raised -
Advaxis: CEO Dan O'Connor
Advaxis: CEO Dan O'ConnorAdvaxis: CEO Dan O'Connor
Dan O'Connor, President and CEO of Advaxis, discusses his company's near term and long term goals. -
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancerFox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Drs. Marc Siegel and David Samadi discuss Advaxis's cancer immunotherapy as a potential treatment for a range of cancer indications, including breast, prostate, osteosarcoma, and head and neck, due to its potential to trigger the immune system to directly attack cancer cells. -
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoiceAdvaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Tom Moore, Chairman and CEO of Advaxis, discusses the company's business model, immunotherapy pipeline, targeted markets, and recent developments. The interv... -
Clinical Trial for Tonsil and Tongue Base Cancer
Clinical Trial for Tonsil and Tongue Base CancerClinical Trial for Tonsil and Tongue Base Cancer
Researchers at Mount Sinai are now conducting a therapeutic clinical trial testing a novel vaccine (ADXS11-001) for patients with HPV-related oropharyngeal (... -
$ADXS, $AAPL, $CAM, $UNP, $SPY : Gaps via twitter 2015 04 23
$ADXS, $AAPL, $CAM, $UNP, $SPY : Gaps via twitter 2015 04 23$ADXS, $AAPL, $CAM, $UNP, $SPY : Gaps via twitter 2015 04 23
http://shugyotrading.blogspot.com/2015/04/adxs-aapl-cam-unp-spy-gaps-via-twitter.html Gaps de la sesión: $ADXS (Advaxis, Inc.), $AAPL (Apple Inc.), $CAM (Cameron International Corporation), $UNP (Union Pacific Corporation) -
Advaxis: Robert Petit
Advaxis: Robert PetitAdvaxis: Robert Petit
Cheif Medical Officer Robert Petit discusses his background and what he sees in the future for Advaxis. -
Daniel O'Connor talks cancer immunotherapy company Advaxis
Daniel O'Connor talks cancer immunotherapy company AdvaxisDaniel O'Connor talks cancer immunotherapy company Advaxis
09/20/13 In an exclusive interview, Daniel O'Connor, CEO and president of Advaxis, talks company history, progress, and it's technology platform. Also, Mr. O... -
Advaxis at the 2010 OneMedForum
Advaxis at the 2010 OneMedForumAdvaxis at the 2010 OneMedForum
OneMedTV captures Thomas A. Moore, CEO of Advaxis, at the 2010 OneMedForum in San Francisco. OneMedTV is the video production department of OneMedPlace, a re... -
BLOX, FEYE, ITCI, NPTN - Harry Boxer, TheTechTrader.com
BLOX, FEYE, ITCI, NPTN - Harry Boxer, TheTechTrader.comBLOX, FEYE, ITCI, NPTN - Harry Boxer, TheTechTrader.com
05/28/15 - www.TheTechTrader.com - It was an interesting day on Wall Street. The markets came down, held support and rallied the entire day until the very end. A lot of our stocks are still trending. Let’s take a look at some of them. Infoblox Inc. (BLOX), one of our long-term plays and recent swing trades, over the last several sessions popped, pulled back, popped again, pulled back, held each time, finally moved on Wednesday, then pulled back again to retest, only to close about a dollar off the low, up 26 cents to 26.32, or 1%, on 1.6 million shares on Thursday. The volume picked up as it went up. Look for it to head up toward 28 1/4-1/2. -
CLVS, DXCM, ECA, FOLD - Harry Boxer, TheTechTrader.com
CLVS, DXCM, ECA, FOLD - Harry Boxer, TheTechTrader.comCLVS, DXCM, ECA, FOLD - Harry Boxer, TheTechTrader.com
9/10/15 - www.TheTechTrader.com - The market had a topsy-turvy kind of session today, but managed to finish in the green column. At the end of the day they bounced back. So, they were up in the morning, down in the afternoon, and back up at the close. Individually, a lot of stocks acted well today, particularly biotech stocks. Let's take a look at some of them. Clovis Oncology, Inc. (CLVS) made big moves in the last couple weeks. In the last two days it popped after the declining channel broke. It ran hard both days and exploded on Thursday to 104.25, up a whopping 8.20, or 9%, on 2 million shares. Keep and eye on this one. DexCom, Inc. (DX -
OneMedRadio: Thomas Moore, CEO of Advaxis
OneMedRadio: Thomas Moore, CEO of AdvaxisOneMedRadio: Thomas Moore, CEO of Advaxis
OneMedRadio interviews Thomas Moore, CEO of Advaxis. -
OneMedRadio: Thomas Moore of Advaxis
OneMedRadio: Thomas Moore of AdvaxisOneMedRadio: Thomas Moore of Advaxis
OneMedRadio interviews Thomas Moore of Advaxis.
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
- Order: Reorder
- Duration: 7:00
- Updated: 18 Jul 2014
- author: Stock News Now
SNNLive spoke with Thomas Moore, Chairman and CEO of Advaxis, Inc. (ADXS:OTCBB) at the 2013 Biotech, Healthcare, Life Science Week in San Francisco, CA. For ...
wn.com/Snnlive With Advaxis, Inc. Update On Clinical Trial For Cervical Cancer
SNNLive spoke with Thomas Moore, Chairman and CEO of Advaxis, Inc. (ADXS:OTCBB) at the 2013 Biotech, Healthcare, Life Science Week in San Francisco, CA. For ...
- published: 25 Jan 2013
- views: 314
- author: Stock News Now
**Video Chart** -- $ADXS Advaxis Inc
- Order: Reorder
- Duration: 4:44
- Updated: 12 Apr 2015
This is a video chart analysis of Advaxis (ADXS) as of April 12th, 2015
wn.com/Video Chart Adxs Advaxis Inc
This is a video chart analysis of Advaxis (ADXS) as of April 12th, 2015
- published: 12 Apr 2015
- views: 64
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
- Order: Reorder
- Duration: 6:06
- Updated: 28 Aug 2013
- author: AllPennyStocks
After a climb from 10 cents that reached a peak at nearly 20 cents, the ADXS chart has retraced, but is establishing a new higher low. Tuesday was a strong v...
wn.com/Advaxis, Inc. (Adxs.Ob) Annotated Stock Chart
After a climb from 10 cents that reached a peak at nearly 20 cents, the ADXS chart has retraced, but is establishing a new higher low. Tuesday was a strong v...
- published: 15 Dec 2010
- views: 282
- author: AllPennyStocks
Adaxis's Trojan Horse Technology™
- Order: Reorder
- Duration: 1:47
- Updated: 06 Oct 2014
Advaxis is developing multiple cancer immunotherapies based on our proprietary platform intended to teach the immune system to kill cancer and extend survival. Our researchers are studying the effect of using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), to actively suppress key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack. Our goal is to create a standard of care that is more effective and more tolerable than traditional chemotherapy or radiation. Watch our short video to learn more about the science behind the investigational therapies we are studying. Learn more: www.advaxis.com
wn.com/Adaxis's Trojan Horse Technology™
Advaxis is developing multiple cancer immunotherapies based on our proprietary platform intended to teach the immune system to kill cancer and extend survival. Our researchers are studying the effect of using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), to actively suppress key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack. Our goal is to create a standard of care that is more effective and more tolerable than traditional chemotherapy or radiation. Watch our short video to learn more about the science behind the investigational therapies we are studying. Learn more: www.advaxis.com
- published: 06 Oct 2014
- views: 114
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
- Order: Reorder
- Duration: 10:39
- Updated: 15 Apr 2015
4/14/15 - https://www.thetechtrader.com - Even though the markets were mixed on Tuesday, a lot of our stocks continue to mow ahead. We have a lot of those stocks to cover here.
Advaxis, Inc. (ADXS) has tripled, going from the low of 6.95 to over 22.00 on Tuesday in just a couple months. It looks like it doesn’t have any momentum lost at this point. It was up 1.19 to 21.78, or 5.78%, on 21 million shares. It may blow through the upper-channel line at some point, running up to the high 20’s, low 30’s, but for now, just keep raising your stops. It’s had five consecutive lower highs, along with some higher highs, so, as a result, it may continue its momentum, but keep close tabs on it. I would still keep a stop under 19-19 1/4.
Capnia, Inc. (CAPN) had a very quiet, inside day, closing up 10 cents to 7.18 on the session, the volume being the lowest it’s been since we’ve been following it. It looks like it’s on the verge of something. We won’t know what it means until it breaks out or down. Negative news wouldn’t be nice, but positive news could gap this above 10, and run up to the mid-teens.
Oasis Petroleum Inc. (OAS) has a great-looking chart. It was put out as a swing trade on Tuesday, because it broke out of a flag, and closed at 18.01, up 1.05, or 6%, on 7.8 million shares. Be looking for a test of the 19.63 area short-term, and then a run to 22 1/2 intermediate-term. Those are the swing trade targets. It has a beautiful base after a long drop. In July we traded at 58.00, and by Dec it dropped all the way down to 10.00, and change. It has moved back up, based out, and this base alone could move this stock to the high 20’s, or even to the low-to-mid 30’s, eventually.
Tower Semiconductor Ltd. (TSEM) is one of our favorite semiconductors, and has been all year, and is coming out of a nice-looking coil pattern. It popped 78 cents to 17.61, or 4.6%, on nearly a million shares. That’s the best volume in a couple weeks. The key breakout is going to come when it crosses 18.30. Watch for 20, and 22 1/2 as the next targets.
Other stocks on Harry’s Charts of the Day included Advaxis, Inc. (ADXS), Alcatel-Lucent (ALU), AirMedia Group Inc. (AMCN), Builders FirstSource, Inc. (BLDR), BroadSoft, Inc. (BSFT), Capnia, Inc. (CAPN), Cara Therapeutics Inc. (CARA), CIENA Corp., C&J; Energy Services, Inc. (CJES), Clean Energy Fuels Corp. (CLNE), Second Sight Medical Products, Inc. (EYES), GW Pharmaceuticals (GWPH), Intra-Cellular Therapies, Inc. (ITCI), Novogen Limited (NVGN), Oasis Petroleum Inc. (OAS), Opko Health, Inc. (OPK), Solazyme, Inc. (SZYM), Tower Semiconductor Ltd. (TSEM), Voltari Corporation (VLTC), and ZIOPHARM Oncology, Inc. (ZIOP). https://www.thetechtrader.com
wn.com/Adxs, Capn, Oas, Tsem Harry Boxer Charts To Watch
4/14/15 - https://www.thetechtrader.com - Even though the markets were mixed on Tuesday, a lot of our stocks continue to mow ahead. We have a lot of those stocks to cover here.
Advaxis, Inc. (ADXS) has tripled, going from the low of 6.95 to over 22.00 on Tuesday in just a couple months. It looks like it doesn’t have any momentum lost at this point. It was up 1.19 to 21.78, or 5.78%, on 21 million shares. It may blow through the upper-channel line at some point, running up to the high 20’s, low 30’s, but for now, just keep raising your stops. It’s had five consecutive lower highs, along with some higher highs, so, as a result, it may continue its momentum, but keep close tabs on it. I would still keep a stop under 19-19 1/4.
Capnia, Inc. (CAPN) had a very quiet, inside day, closing up 10 cents to 7.18 on the session, the volume being the lowest it’s been since we’ve been following it. It looks like it’s on the verge of something. We won’t know what it means until it breaks out or down. Negative news wouldn’t be nice, but positive news could gap this above 10, and run up to the mid-teens.
Oasis Petroleum Inc. (OAS) has a great-looking chart. It was put out as a swing trade on Tuesday, because it broke out of a flag, and closed at 18.01, up 1.05, or 6%, on 7.8 million shares. Be looking for a test of the 19.63 area short-term, and then a run to 22 1/2 intermediate-term. Those are the swing trade targets. It has a beautiful base after a long drop. In July we traded at 58.00, and by Dec it dropped all the way down to 10.00, and change. It has moved back up, based out, and this base alone could move this stock to the high 20’s, or even to the low-to-mid 30’s, eventually.
Tower Semiconductor Ltd. (TSEM) is one of our favorite semiconductors, and has been all year, and is coming out of a nice-looking coil pattern. It popped 78 cents to 17.61, or 4.6%, on nearly a million shares. That’s the best volume in a couple weeks. The key breakout is going to come when it crosses 18.30. Watch for 20, and 22 1/2 as the next targets.
Other stocks on Harry’s Charts of the Day included Advaxis, Inc. (ADXS), Alcatel-Lucent (ALU), AirMedia Group Inc. (AMCN), Builders FirstSource, Inc. (BLDR), BroadSoft, Inc. (BSFT), Capnia, Inc. (CAPN), Cara Therapeutics Inc. (CARA), CIENA Corp., C&J; Energy Services, Inc. (CJES), Clean Energy Fuels Corp. (CLNE), Second Sight Medical Products, Inc. (EYES), GW Pharmaceuticals (GWPH), Intra-Cellular Therapies, Inc. (ITCI), Novogen Limited (NVGN), Oasis Petroleum Inc. (OAS), Opko Health, Inc. (OPK), Solazyme, Inc. (SZYM), Tower Semiconductor Ltd. (TSEM), Voltari Corporation (VLTC), and ZIOPHARM Oncology, Inc. (ZIOP). https://www.thetechtrader.com
- published: 15 Apr 2015
- views: 88
Advaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis ADXS-HPV is selected as the "Best Therapeutic Vaccine" at the 2012 World Vaccine Congress in Washington DC. Judges comments and Acceptance by Dr. Joh...
wn.com/Advaxis Receives 2012 Vie Award For Best Therapeutic Vaccine
Advaxis ADXS-HPV is selected as the "Best Therapeutic Vaccine" at the 2012 World Vaccine Congress in Washington DC. Judges comments and Acceptance by Dr. Joh...
- published: 12 Apr 2012
- views: 644
- author: Rg Petit
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
- Order: Reorder
- Duration: 18:41
- Updated: 16 Apr 2015
- published: 16 Apr 2015
- views: 50
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
- Order: Reorder
- Duration: 7:40
- Updated: 15 Sep 2015
9/15/15 - www.TheTechTrader.com - It was a very good day on Wall Street on Tuesday. The markets rallied all day, and in the last hour they pulled back a little bit, but not much. I like the way they closed. I like the way a lot of our stocks acted. So, let’s take a look at some old ones and some new ones
Aceto Corp. (ACET), which we mentioned over the weekend, had an inside day on Monday, and on Tuesday it popped 1.70 to 28.87, or 6%, on nearly a half million shares, reaching as high as 29.82. This stock has a long uptrend from a low of 4.50-5.00 back in 2011, and is now up in the high 20’s. Looking at the overall picture, these are all-time highs. Recently, in July, after popping up to the 27.00 range, it came down in a 3-wave corrective pullback, tested the earlier breakout point in the 21.43 area, and then exploded off that point. It has gone from 21, and change, to almost 30, in a week. If it follows through, look for a run up to the mid-30’s, and then the mid-40’s going forward.
Advaxis, Inc. (ADXS) is acting great, up four days in a row out of the last seven, in particular, the volume picked up three days in a row. On Tuesday, it popped 1.64 to 19.49, or 9.2%, on nearly 3 million shares, with a high of 28.88, although it did pull back late in the day on profit taking. It looks like this stock still has more to go. The targets are near 24, and then all the way up near 30. If it gets through that zone, it’s looking at a big number down the road.
Inotek Pharmaceuticals Corporation (ITEK) made the breakout across the declining topsline on Tuesday that I wanted to see happen, and through the prior high, which also happened on Tuesday. It was up 1.57 to 14.57, or 12%. Look for a run to the prior high up around the 16.40-.45 range, and if it gets through that, look for it to run up to the 19.45 area. So, the targets are 16 1/2 and 19 1/2.
Sucampo Pharmaceuticals, Inc. (SCMP) has a very, very nice pattern, an explosive-move flag, it popped, pulled back and tested several times in a nice, orderly pattern. On Tuesday the top of that channel may have been challenged at 39-40, possibly in the next day, or so, and then look for 46.
Other stocks on the long side include AxoGen, Inc. (AXGN), Exelixis, Inc. (EXEL), GW Pharmaceuticals plc (GWPH), Lexicon Pharmaceuticals, Inc. (LXRX), Maxwell Technologies, Inc. (MXWL), Seattle Genetics, Inc. (SGEN), Sarepta Therapeutics, Inc. (SRPT), Trevena, Inc. (TRVN), and Weight Watchers International, Inc. (WTW). http://www.TheTechTrader.com
wn.com/Acet, Adxs, Itek, Scmp Harry Boxer, Thetechtrader.Com
9/15/15 - www.TheTechTrader.com - It was a very good day on Wall Street on Tuesday. The markets rallied all day, and in the last hour they pulled back a little bit, but not much. I like the way they closed. I like the way a lot of our stocks acted. So, let’s take a look at some old ones and some new ones
Aceto Corp. (ACET), which we mentioned over the weekend, had an inside day on Monday, and on Tuesday it popped 1.70 to 28.87, or 6%, on nearly a half million shares, reaching as high as 29.82. This stock has a long uptrend from a low of 4.50-5.00 back in 2011, and is now up in the high 20’s. Looking at the overall picture, these are all-time highs. Recently, in July, after popping up to the 27.00 range, it came down in a 3-wave corrective pullback, tested the earlier breakout point in the 21.43 area, and then exploded off that point. It has gone from 21, and change, to almost 30, in a week. If it follows through, look for a run up to the mid-30’s, and then the mid-40’s going forward.
Advaxis, Inc. (ADXS) is acting great, up four days in a row out of the last seven, in particular, the volume picked up three days in a row. On Tuesday, it popped 1.64 to 19.49, or 9.2%, on nearly 3 million shares, with a high of 28.88, although it did pull back late in the day on profit taking. It looks like this stock still has more to go. The targets are near 24, and then all the way up near 30. If it gets through that zone, it’s looking at a big number down the road.
Inotek Pharmaceuticals Corporation (ITEK) made the breakout across the declining topsline on Tuesday that I wanted to see happen, and through the prior high, which also happened on Tuesday. It was up 1.57 to 14.57, or 12%. Look for a run to the prior high up around the 16.40-.45 range, and if it gets through that, look for it to run up to the 19.45 area. So, the targets are 16 1/2 and 19 1/2.
Sucampo Pharmaceuticals, Inc. (SCMP) has a very, very nice pattern, an explosive-move flag, it popped, pulled back and tested several times in a nice, orderly pattern. On Tuesday the top of that channel may have been challenged at 39-40, possibly in the next day, or so, and then look for 46.
Other stocks on the long side include AxoGen, Inc. (AXGN), Exelixis, Inc. (EXEL), GW Pharmaceuticals plc (GWPH), Lexicon Pharmaceuticals, Inc. (LXRX), Maxwell Technologies, Inc. (MXWL), Seattle Genetics, Inc. (SGEN), Sarepta Therapeutics, Inc. (SRPT), Trevena, Inc. (TRVN), and Weight Watchers International, Inc. (WTW). http://www.TheTechTrader.com
- published: 15 Sep 2015
- views: 15
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
- Order: Reorder
- Duration: 1:29
- Updated: 23 Apr 2011
- author: Stocktrendnews
Cash Flow from Operations for Advaxis, Inc. for its quarter ended January 31st was minus $2.1 million, a 152% deterioration over the year earlier same quarte...
wn.com/Advaxis Cffo Off 152 Global Financial News Minute With Donald Baillargeon
Cash Flow from Operations for Advaxis, Inc. for its quarter ended January 31st was minus $2.1 million, a 152% deterioration over the year earlier same quarte...
- published: 23 Apr 2011
- views: 176
- author: Stocktrendnews
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
- Order: Reorder
- Duration: 6:39
- Updated: 01 Apr 2015
03/31/15 - http//www.TheTechTrader.com - The markets did not have a good day on this turnaround Tuesday. A lot of our stocks did well, so let’s go over a few old ones and new ones.
Advaxis, Inc. (ADXS) impressed me by jumping a dollar. It didn’t hold the high, but it got up to a penny off the high at 15. It backed off about 50 cents and closed at 14.44, up 1.00, or 7 1/2%, on 1.86 million shares. That’s the best volume on an up day in a couple weeks. If it could just get a follow-through, we could see 18 or 19 on this stock.
Capnia, Inc. (CAPN) popped on Tuesday, up 34 cents to 6.40, or 5.6%, on 7.8 million shares. It went up to 6.95, but couldn’t quite get through the 7.00 level. The line of resistance at that level is still holding. Watch this one carefully. The technicals look good, the OBV is at a new high. Look for a run at the 8.00 range, and then a test of 9 3/4. Beyond that we could see 12 or 13, but let’s take it one step at a time.
Syneron Medical Ltd. (ELOS), a swing trade, has been acting well. It broke out, pulled back, had a nominal breakout, but couldn’t follow through, and backed off one more time on low volume and good technicals. On Tuesday, it popped from 11.67 to 12.99, and closed at 12.39, up 71 cents, or 6%, on 360,000 shares traded. That’s big volume for this stock, the second biggest volume in about 4 weeks. Let’s see if it get to my targets at 13 1/4 and 14 1/2.
Spark Therapeutics, Inc. (ONCE) is a recent IPO biotech, and one of the favorites, having gone from 65 to 79 in the last three consecutive days. The target is now 86-7.
Other stocks on Harry’s Charts of the Day included Arista Networks, Inc. (ANET), CorMedix, Inc. (CRMD), Dyax Corp. (DYAX), Syneron Medical Ltd. (ELOS), Great Basin Scientific, Inc. (GBSN), Genetic Technologies Limited (GENE), Gordmans Stores, Inc. (GMAN), 2U, Inc. (TWOU), and Unilife Corporation (UNIS).
wn.com/Adxs, Capn, Elos, Once – Stock Charts Harry Boxer, Thetechtrader.Com
03/31/15 - http//www.TheTechTrader.com - The markets did not have a good day on this turnaround Tuesday. A lot of our stocks did well, so let’s go over a few old ones and new ones.
Advaxis, Inc. (ADXS) impressed me by jumping a dollar. It didn’t hold the high, but it got up to a penny off the high at 15. It backed off about 50 cents and closed at 14.44, up 1.00, or 7 1/2%, on 1.86 million shares. That’s the best volume on an up day in a couple weeks. If it could just get a follow-through, we could see 18 or 19 on this stock.
Capnia, Inc. (CAPN) popped on Tuesday, up 34 cents to 6.40, or 5.6%, on 7.8 million shares. It went up to 6.95, but couldn’t quite get through the 7.00 level. The line of resistance at that level is still holding. Watch this one carefully. The technicals look good, the OBV is at a new high. Look for a run at the 8.00 range, and then a test of 9 3/4. Beyond that we could see 12 or 13, but let’s take it one step at a time.
Syneron Medical Ltd. (ELOS), a swing trade, has been acting well. It broke out, pulled back, had a nominal breakout, but couldn’t follow through, and backed off one more time on low volume and good technicals. On Tuesday, it popped from 11.67 to 12.99, and closed at 12.39, up 71 cents, or 6%, on 360,000 shares traded. That’s big volume for this stock, the second biggest volume in about 4 weeks. Let’s see if it get to my targets at 13 1/4 and 14 1/2.
Spark Therapeutics, Inc. (ONCE) is a recent IPO biotech, and one of the favorites, having gone from 65 to 79 in the last three consecutive days. The target is now 86-7.
Other stocks on Harry’s Charts of the Day included Arista Networks, Inc. (ANET), CorMedix, Inc. (CRMD), Dyax Corp. (DYAX), Syneron Medical Ltd. (ELOS), Great Basin Scientific, Inc. (GBSN), Genetic Technologies Limited (GENE), Gordmans Stores, Inc. (GMAN), 2U, Inc. (TWOU), and Unilife Corporation (UNIS).
- published: 01 Apr 2015
- views: 13
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
- Order: Reorder
- Duration: 2:57
- Updated: 15 Jan 2015
Advaxis has seen its shares surge higher in the past month due to increased institutional interest and an optimistic response from investors to its 2015 outlook, said the company's CEO Dan O'Connor. O'Connor added that Boston's Adage Capital and T. Rowe Price are the large players that have taken significant positions in Advaxis. He said Advaxis has partnerships with Merck and MedImmune to explore their immunotherapy technology in combination with other agents and is seeking additional partners. O'Connor said he expects to start a Phase 3 trial for its cervical cancer therapy in the first half of 2015. Finally, he said the company has raised enough money to operate until July 2016 without a significant change in its operations.
Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV
For more content from TheStreet visit: http://thestreet.com
Check out all our videos: http://youtube.com/user/TheStreetTV
Follow TheStreet on Twitter: http://twitter.com/thestreet
Like TheStreet on Facebook: http://facebook.com/TheStreet
Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet
Follow TheStreet on Google+: http://plus.google.com/+TheStreet
wn.com/Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
Advaxis has seen its shares surge higher in the past month due to increased institutional interest and an optimistic response from investors to its 2015 outlook, said the company's CEO Dan O'Connor. O'Connor added that Boston's Adage Capital and T. Rowe Price are the large players that have taken significant positions in Advaxis. He said Advaxis has partnerships with Merck and MedImmune to explore their immunotherapy technology in combination with other agents and is seeking additional partners. O'Connor said he expects to start a Phase 3 trial for its cervical cancer therapy in the first half of 2015. Finally, he said the company has raised enough money to operate until July 2016 without a significant change in its operations.
Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV
For more content from TheStreet visit: http://thestreet.com
Check out all our videos: http://youtube.com/user/TheStreetTV
Follow TheStreet on Twitter: http://twitter.com/thestreet
Like TheStreet on Facebook: http://facebook.com/TheStreet
Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet
Follow TheStreet on Google+: http://plus.google.com/+TheStreet
- published: 15 Jan 2015
- views: 34
Advaxis: CEO Dan O'Connor
- Order: Reorder
- Duration: 2:12
- Updated: 15 Feb 2014
- author: Executive Video
Dan O'Connor, President and CEO of Advaxis, discusses his company's near term and long term goals.
wn.com/Advaxis Ceo Dan O'Connor
Dan O'Connor, President and CEO of Advaxis, discusses his company's near term and long term goals.
- published: 12 Feb 2014
- views: 137
- author: Executive Video
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
- Order: Reorder
- Duration: 4:13
- Updated: 30 Dec 2014
Drs. Marc Siegel and David Samadi discuss Advaxis's cancer immunotherapy as a potential treatment for a range of cancer indications, including breast, prostate, osteosarcoma, and head and neck, due to its potential to trigger the immune system to directly attack cancer cells.
wn.com/Fox News’ Sunday Housecall Experimental Treatment Uses Immune System To Fight Cancer
Drs. Marc Siegel and David Samadi discuss Advaxis's cancer immunotherapy as a potential treatment for a range of cancer indications, including breast, prostate, osteosarcoma, and head and neck, due to its potential to trigger the immune system to directly attack cancer cells.
- published: 30 Dec 2014
- views: 7
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
- Order: Reorder
- Duration: 18:41
- Updated: 20 Feb 2013
- author: QualityStocks
Tom Moore, Chairman and CEO of Advaxis, discusses the company's business model, immunotherapy pipeline, targeted markets, and recent developments. The interv...
wn.com/Advaxis, Inc. (Adxs) Chairman And Ceo Interviewed By Smallcapvoice
Tom Moore, Chairman and CEO of Advaxis, discusses the company's business model, immunotherapy pipeline, targeted markets, and recent developments. The interv...
- published: 20 Feb 2013
- views: 113
- author: QualityStocks
Clinical Trial for Tonsil and Tongue Base Cancer
- Order: Reorder
- Duration: 3:16
- Updated: 23 Aug 2014
- author: Mount Sinai Hospital
Researchers at Mount Sinai are now conducting a therapeutic clinical trial testing a novel vaccine (ADXS11-001) for patients with HPV-related oropharyngeal (...
wn.com/Clinical Trial For Tonsil And Tongue Base Cancer
Researchers at Mount Sinai are now conducting a therapeutic clinical trial testing a novel vaccine (ADXS11-001) for patients with HPV-related oropharyngeal (...
- published: 09 Jul 2014
- views: 262
- author: Mount Sinai Hospital
$ADXS, $AAPL, $CAM, $UNP, $SPY : Gaps via twitter 2015 04 23
- Order: Reorder
- Duration: 4:29
- Updated: 23 Apr 2015
http://shugyotrading.blogspot.com/2015/04/adxs-aapl-cam-unp-spy-gaps-via-twitter.html
Gaps de la sesión: $ADXS (Advaxis, Inc.), $AAPL (Apple Inc.), $CAM (Cameron International Corporation), $UNP (Union Pacific Corporation)
wn.com/Adxs, Aapl, Cam, Unp, Spy Gaps Via Twitter 2015 04 23
http://shugyotrading.blogspot.com/2015/04/adxs-aapl-cam-unp-spy-gaps-via-twitter.html
Gaps de la sesión: $ADXS (Advaxis, Inc.), $AAPL (Apple Inc.), $CAM (Cameron International Corporation), $UNP (Union Pacific Corporation)
- published: 23 Apr 2015
- views: 8
Advaxis: Robert Petit
- Order: Reorder
- Duration: 2:25
- Updated: 12 Feb 2014
Cheif Medical Officer Robert Petit discusses his background and what he sees in the future for Advaxis.
wn.com/Advaxis Robert Petit
Cheif Medical Officer Robert Petit discusses his background and what he sees in the future for Advaxis.
- published: 12 Feb 2014
- views: 2
Daniel O'Connor talks cancer immunotherapy company Advaxis
- Order: Reorder
- Duration: 5:41
- Updated: 01 Apr 2014
- author: Pierre Alexandre
09/20/13 In an exclusive interview, Daniel O'Connor, CEO and president of Advaxis, talks company history, progress, and it's technology platform. Also, Mr. O...
wn.com/Daniel O'Connor Talks Cancer Immunotherapy Company Advaxis
09/20/13 In an exclusive interview, Daniel O'Connor, CEO and president of Advaxis, talks company history, progress, and it's technology platform. Also, Mr. O...
- published: 21 Sep 2013
- views: 131
- author: Pierre Alexandre
Advaxis at the 2010 OneMedForum
- Order: Reorder
- Duration: 7:08
- Updated: 08 May 2011
- author: OneMedPlace
OneMedTV captures Thomas A. Moore, CEO of Advaxis, at the 2010 OneMedForum in San Francisco. OneMedTV is the video production department of OneMedPlace, a re...
wn.com/Advaxis At The 2010 Onemedforum
OneMedTV captures Thomas A. Moore, CEO of Advaxis, at the 2010 OneMedForum in San Francisco. OneMedTV is the video production department of OneMedPlace, a re...
- published: 03 Feb 2010
- views: 510
- author: OneMedPlace
BLOX, FEYE, ITCI, NPTN - Harry Boxer, TheTechTrader.com
- Order: Reorder
- Duration: 9:02
- Updated: 29 May 2015
05/28/15 - www.TheTechTrader.com - It was an interesting day on Wall Street. The markets came down, held support and rallied the entire day until the very end. A lot of our stocks are still trending. Let’s take a look at some of them.
Infoblox Inc. (BLOX), one of our long-term plays and recent swing trades, over the last several sessions popped, pulled back, popped again, pulled back, held each time, finally moved on Wednesday, then pulled back again to retest, only to close about a dollar off the low, up 26 cents to 26.32, or 1%, on 1.6 million shares on Thursday. The volume picked up as it went up. Look for it to head up toward 28 1/4-1/2. Let’s see if it gets an extension to rally to get to that. If it gets through that, then it’s on its way to the 31-32 zone, which is the short-term target.
FireEye, Inc. (FEYE) has been acting great. It had a good day on Thursday, up 1.81 to 46.82, taking out the March high at 46.44, or 4%, on 13 million shares. That's the best volume since February. The way it looks now this stock wants to head higher. Targets are up around 50 short-term, 55-56 intermediate-term, and then 61-63 long-term. This stock appears to be at the breakout point of the basing pattern.
Intra-Cellular Therapies, Inc. (ITCI), which we put out a swing on Thursday, failed on an earlier swing and came down in a 3-wave corrective pullback to a major channel bottom. Over the last few weeks it’s shown steady progress. On Thursday it was up 73 cents to 26.62, or 2.8%, on 211,561 shares traded. It looks like it’s going to start with a move to 28 1/2-3/4, and if it gets through that, then the targets are 31 short-term, 35 intermediate-term, and 38 long-term.
NeoPhotonics Corporation (NPTN), one of our swing trades, is acting great after popping and pulling back. It’s gone up steadily, reaching 8.65 on Thursday, and closing at 8.62, up 35 cents, or 4 1/4%, on nearly a million shares traded. Potential targets are 10 and 12 1/2.
Other stocks on Harry’s Charts of the Day included Advaxis, Inc. (ADXS), BSQUARE Corp. (BSQR), Cellectis S.A. (CLLS), CARBO Ceramics Inc. (CRR), Second Sight Medical Products, Inc. (EYES), GoPro, Inc. (GPRO), Infinera Corporation (INFN), Juno Therapeutics Inc. (JUNO), McDermott International Inc. (MDR), Sorrento Therapeutics, Inc. (SRNE), SunEdison, Inc. (SUNE), TubeMogul, Inc. (TUBE), and XOMA Corporation (XOMA). http://www.TheTechTrader.com
wn.com/Blox, Feye, Itci, Nptn Harry Boxer, Thetechtrader.Com
05/28/15 - www.TheTechTrader.com - It was an interesting day on Wall Street. The markets came down, held support and rallied the entire day until the very end. A lot of our stocks are still trending. Let’s take a look at some of them.
Infoblox Inc. (BLOX), one of our long-term plays and recent swing trades, over the last several sessions popped, pulled back, popped again, pulled back, held each time, finally moved on Wednesday, then pulled back again to retest, only to close about a dollar off the low, up 26 cents to 26.32, or 1%, on 1.6 million shares on Thursday. The volume picked up as it went up. Look for it to head up toward 28 1/4-1/2. Let’s see if it gets an extension to rally to get to that. If it gets through that, then it’s on its way to the 31-32 zone, which is the short-term target.
FireEye, Inc. (FEYE) has been acting great. It had a good day on Thursday, up 1.81 to 46.82, taking out the March high at 46.44, or 4%, on 13 million shares. That's the best volume since February. The way it looks now this stock wants to head higher. Targets are up around 50 short-term, 55-56 intermediate-term, and then 61-63 long-term. This stock appears to be at the breakout point of the basing pattern.
Intra-Cellular Therapies, Inc. (ITCI), which we put out a swing on Thursday, failed on an earlier swing and came down in a 3-wave corrective pullback to a major channel bottom. Over the last few weeks it’s shown steady progress. On Thursday it was up 73 cents to 26.62, or 2.8%, on 211,561 shares traded. It looks like it’s going to start with a move to 28 1/2-3/4, and if it gets through that, then the targets are 31 short-term, 35 intermediate-term, and 38 long-term.
NeoPhotonics Corporation (NPTN), one of our swing trades, is acting great after popping and pulling back. It’s gone up steadily, reaching 8.65 on Thursday, and closing at 8.62, up 35 cents, or 4 1/4%, on nearly a million shares traded. Potential targets are 10 and 12 1/2.
Other stocks on Harry’s Charts of the Day included Advaxis, Inc. (ADXS), BSQUARE Corp. (BSQR), Cellectis S.A. (CLLS), CARBO Ceramics Inc. (CRR), Second Sight Medical Products, Inc. (EYES), GoPro, Inc. (GPRO), Infinera Corporation (INFN), Juno Therapeutics Inc. (JUNO), McDermott International Inc. (MDR), Sorrento Therapeutics, Inc. (SRNE), SunEdison, Inc. (SUNE), TubeMogul, Inc. (TUBE), and XOMA Corporation (XOMA). http://www.TheTechTrader.com
- published: 29 May 2015
- views: 30
CLVS, DXCM, ECA, FOLD - Harry Boxer, TheTechTrader.com
- Order: Reorder
- Duration: 5:08
- Updated: 10 Sep 2015
9/10/15 - www.TheTechTrader.com - The market had a topsy-turvy kind of session today, but managed to finish in the green column. At the end of the day they bounced back. So, they were up in the morning, down in the afternoon, and back up at the close. Individually, a lot of stocks acted well today, particularly biotech stocks. Let's take a look at some of them.
Clovis Oncology, Inc. (CLVS) made big moves in the last couple weeks. In the last two days it popped after the declining channel broke. It ran hard both days and exploded on Thursday to 104.25, up a whopping 8.20, or 9%, on 2 million shares. Keep and eye on this one.
DexCom, Inc. (DXCM) had a very good day on Thursday, up 5.59 to 96.43, or 6%, on 1.7 million shares. There’s a wedge here that was broken. Look for highs around 98-99, and if it gets through that, the target is 106-7.
Encana Corporation (ECA) has a very interesting pattern with a little head-and-shoulder’s bottom. A lot of the oil stocks are starting to act a little better, including this one. It popped 25 cents to 7.21, or 4%, on 13.7 million shares on Thursday. Look for a move to 7.50-.55. If it gets through that, the targets are 8 1/2 and 9 1/2 going forward.
Amicus Therapeutics, Inc. (FOLD) has been acting great. On Thursday, it was up another 89 cents to 17.95, or 5.2%, on 1.8 million shares. It extended on Thursday, so be looking for a test of the recent highs at 18.80-.83. If it gets through there, look for a run that takes this into the mid 20’s, around 25.
Other stocks on the long side include Advaxis, Inc. (ADXS), Anacor Pharmaceuticals, Inc. (ANAC), EDAP TMS SA (EDAP), Extreme Networks Inc. (EXTR), FibroGen, Inc. (FGEN), Inteliquent, Inc. (IQNT), Midstates Petroleum Company, Inc. (MPO), Neurocrine Biosciences Inc. (NBIX), Sangamo Biosciences Inc. (SGMO), Straight Path Communications Inc. (STRP), and ZELTIQ Aesthetics, Inc. (ZLTQ). http://www.TheTechTrader.com
wn.com/Clvs, Dxcm, Eca, Fold Harry Boxer, Thetechtrader.Com
9/10/15 - www.TheTechTrader.com - The market had a topsy-turvy kind of session today, but managed to finish in the green column. At the end of the day they bounced back. So, they were up in the morning, down in the afternoon, and back up at the close. Individually, a lot of stocks acted well today, particularly biotech stocks. Let's take a look at some of them.
Clovis Oncology, Inc. (CLVS) made big moves in the last couple weeks. In the last two days it popped after the declining channel broke. It ran hard both days and exploded on Thursday to 104.25, up a whopping 8.20, or 9%, on 2 million shares. Keep and eye on this one.
DexCom, Inc. (DXCM) had a very good day on Thursday, up 5.59 to 96.43, or 6%, on 1.7 million shares. There’s a wedge here that was broken. Look for highs around 98-99, and if it gets through that, the target is 106-7.
Encana Corporation (ECA) has a very interesting pattern with a little head-and-shoulder’s bottom. A lot of the oil stocks are starting to act a little better, including this one. It popped 25 cents to 7.21, or 4%, on 13.7 million shares on Thursday. Look for a move to 7.50-.55. If it gets through that, the targets are 8 1/2 and 9 1/2 going forward.
Amicus Therapeutics, Inc. (FOLD) has been acting great. On Thursday, it was up another 89 cents to 17.95, or 5.2%, on 1.8 million shares. It extended on Thursday, so be looking for a test of the recent highs at 18.80-.83. If it gets through there, look for a run that takes this into the mid 20’s, around 25.
Other stocks on the long side include Advaxis, Inc. (ADXS), Anacor Pharmaceuticals, Inc. (ANAC), EDAP TMS SA (EDAP), Extreme Networks Inc. (EXTR), FibroGen, Inc. (FGEN), Inteliquent, Inc. (IQNT), Midstates Petroleum Company, Inc. (MPO), Neurocrine Biosciences Inc. (NBIX), Sangamo Biosciences Inc. (SGMO), Straight Path Communications Inc. (STRP), and ZELTIQ Aesthetics, Inc. (ZLTQ). http://www.TheTechTrader.com
- published: 10 Sep 2015
- views: 26
OneMedRadio: Thomas Moore, CEO of Advaxis
- Order: Reorder
- Duration: 15:28
- Updated: 19 Nov 2012
- author: OneMedPlace
OneMedRadio interviews Thomas Moore, CEO of Advaxis.
wn.com/Onemedradio Thomas Moore, Ceo Of Advaxis
OneMedRadio interviews Thomas Moore, CEO of Advaxis.
- published: 10 Nov 2011
- views: 187
- author: OneMedPlace
OneMedRadio: Thomas Moore of Advaxis
- Order: Reorder
- Duration: 34:55
- Updated: 22 Dec 2013
- author: OneMedPlace
OneMedRadio interviews Thomas Moore of Advaxis.
wn.com/Onemedradio Thomas Moore Of Advaxis
OneMedRadio interviews Thomas Moore of Advaxis.
- published: 28 Mar 2012
- views: 92
- author: OneMedPlace
-
MarkupReport.com Top Breakout Stocks 8-25-2014
MarkupReport.com Top Breakout Stocks 8-25-2014MarkupReport.com Top Breakout Stocks 8-25-2014
Test Drive the Markup Report today at http://markupreport.com/subscribe/ Ticker Name DGLY Digital Ally Inc ITMN InterMune Inc. ADXS Advaxis Inc. HGSH China HGS Real Es BKW Burger King World MOBL MobileIron Inc. ATHM Autohome Inc. Ame AXDX Accelerate Diagno BITA Bitauto Holdings ACHN Achillion Pharmac CXDC China XD Plastics CPRX Catalyst Pharmace KANG iKang Healthcare LRAD LRAD Corporation SCLN SciClone Pharmace KERX Keryx Biopharmace RCPT Receptos Inc. ROYT Pacific Coast Oil CRNT Ceragon Networks CLVS Clovis Oncology ANN ANN INC. Common S POZN Pozen Inc. MNDO MIND C.T.I. Ltd. VNET 21Vianet Group I NKTR Nektar Therapeuti GEVA Synageva Bi
MarkupReport.com Top Breakout Stocks 8-25-2014
- Order: Reorder
- Duration: 2:30
- Updated: 03 Sep 2014
Test Drive the Markup Report today at
http://markupreport.com/subscribe/
Ticker Name
DGLY Digital Ally Inc
ITMN InterMune Inc.
ADXS Advaxis Inc.
HGSH China HGS Real Es
BKW Burger King World
MOBL MobileIron Inc.
ATHM Autohome Inc. Ame
AXDX Accelerate Diagno
BITA Bitauto Holdings
ACHN Achillion Pharmac
CXDC China XD Plastics
CPRX Catalyst Pharmace
KANG iKang Healthcare
LRAD LRAD Corporation
SCLN SciClone Pharmace
KERX Keryx Biopharmace
RCPT Receptos Inc.
ROYT Pacific Coast Oil
CRNT Ceragon Networks
CLVS Clovis Oncology
ANN ANN INC. Common S
POZN Pozen Inc.
MNDO MIND C.T.I. Ltd.
VNET 21Vianet Group I
NKTR Nektar Therapeuti
GEVA Synageva BioPharm
AXAS Abraxas Petroleum
INCY Incyte Corporatio
WRES Warren Resources
EBIX Ebix Inc.
YGE Yingli Green Ener
PBR Petroleo Brasilei
MDVN Medivation Inc.
CONN Conn's Inc.
BIB ProShares Ultra N
JCP J.C. Penney Compa
PBR.A PBR.A
SM SM Energy Company
AVNR Avanir Pharmaceut
CCIH ChinaCache Intern
PTX Pernix Therapeuti
AMBA Ambarella Inc.
CBOE CBOE Holdings In
CLR Continental Resou
RPRX Repros Therapeuti
NEWM New Media Investm
CODE Spansion Inc Comm
IMMU Immunomedics Inc
NFX Newfield Explorat
ILMN Illumina Inc.
TPLM Triangle Petroleu
IMGN ImmunoGen Inc.
CENX Century Aluminum
BDSI BioDelivery Scien
IOC InterOil Corporat
ICLD InterCloud System
UVE UNIVERSAL INSURAN
WLL Whiting Petroleum
LKQ LKQ Corporation
ACOR Acorda Therapeuti
RRC Range Resources C
INFN Infinera Corporat
EOX Emerald Oil Inc.
PCRX Pacira Pharmaceut
BLDR Builders FirstSou
KOG Kodiak Oil & Gas
X United States Ste
ANAC Anacor Pharmaceut
CZZ Cosan Limited Cla
QRE QR Energy LP Com
FNHC Federated Nationa
ETE Energy Transfer E
DRTX Durata Therapeuti
LNG Cheniere Energy
IBB iShares Nasdaq Bi
CBST Cubist Pharmaceut
HRG Harbinger Group I
TRP TransCanada Corpo
GHL Greenhill & Co.
TXRH Texas Roadhouse
SERV ServiceMaster Glo
KNX Knight Transporta
BLK BlackRock Inc. C
LDRH LDR Holding Corpo
PBYI Puma Biotechnolog
SYRG Synergy Resources
PRTA Prothena Corporat
SNY Sanofi American D
CELG Celgene Corporati
CAM Cameron Internati
AKRX Akorn Inc.
ATHN athenahealth Inc
ITUB Itau Unibanco Ban
BCO Brinks Company (T
GLDD Great Lakes Dredg
PEP Pepsico Inc. Com
ASX Advanced Semicond
TAL TAL International
WWE World Wrestling E
OME Omega Protein Cor
ANDE The Andersons In
PTRY The Pantry Inc.
KKD Krispy Kreme Doug
CAMP CalAmp Corp.
CPL CPFL Energia S.A.
IRDM Iridium Communica
CAKE The Cheesecake Fa
BBEP BreitBurn Energy
ACMP Access Midstream
TCPC TCP Capital Corp.
NDAQ The NASDAQ OMX Gr
NMBL Nimble Storage I
WETF WisdomTree Invest
SPXL Direxion Daily S&
HCBK Hudson City Banco
SKM SK Telecom Co. L
CX Cemex S.A.B. de
WLK Westlake Chemical
UPRO ProShares UltraPr
ENR Energizer Holding
AMGN Amgen Inc.
CLB Core Laboratories
SGEN Seattle Genetics
UBNT Ubiquiti Networks
JPM JP Morgan Chase &
UPL Ultra Petroleum C
BUD Anheuser-Busch In
DEPO Depomed Inc.
UGP Ultrapar Particip
NSM Nationstar Mortga
ERII Energy Recovery
MBT Mobile TeleSystem
JBL Jabil Circuit In
EEP Enbridge Energy
CBI Chicago Bridge &
JAZZ Jazz Pharmaceutic
TNA Direxion Small Ca
CNO CNO Financial Gro
FV First Trust Dorse
ECA Encana Corporatio
YELP Yelp Inc. Class A
ODFL Old Dominion Frei
ACM Aecom Technology
CS Credit Suisse Gro
ABBV AbbVie Inc. Commo
HLSS Home Loan Servici
CHKP Check Point Softw
CTL CenturyLink Inc.
GPRE Green Plains Inc
TK Teekay Corporatio
EL Estee Lauder Comp
ING ING Group N.V. C
L Loews Corporation
SIG Signet Jewelers L
ALL Allstate Corporat
AZN Astrazeneca PLC C
PNW Pinnacle West Cap
CSIQ Canadian Solar In
ORI Old Republic Inte
AXS Axis Capital Hold
BLOX Infoblox Inc. Com
SWHC Smith & Wesson Ho
HIG Hartford Financia
DFS Discover Financia
CE Celanese Corporat
SSO ProShares Ultra S
WIBC Wilshire Bancorp
XIV Credit Suisse AG
BMRN BioMarin Pharmace
STRZA Starz
GWW W.W. Grainger In
BID Sotheby's Common
AIG American Internat
ORLY O'Reilly Automoti
FSLR First Solar Inc.
PFG Principal Financi
ASNA Ascena Retail Gro
RYN Rayonier Inc. REI
SYK Stryker Corporati
SVXY ProShares Short V
MRK Merck & Company
LULU lululemon athleti
PSX Phillips 66 Commo
NMFC New Mountain Fina
CRL Charles River Lab
MOH Molina Healthcare
MRO Marathon Oil Corp
WYN Wyndham Worldwide
NKE Nike Inc. Common
XL XL Group plc
CPRT Copart Inc.
WDR Waddell & Reed Fi
AMCX AMC Networks Inc.
CQB Chiquita Brands I
RGA Reinsurance Group
FII Federated Investo
PNNT PennantPark Inves
IBKR Interactive Broke
GRA W.R. Grace & Co.
VWO Vanguard FTSE Eme
KAR KAR Auction Servi
D Dominion Resource
AGIO Agios Pharmaceuti
PPG PPG Industries I
VC Visteon Corporati
LNCO Linn Co LLC
ECL Ecolab Inc. Commo
SBY Silver Bay Realty
NOV National Oilwell
MSM MSC Industrial Di
TGI Triumph Group In
ROK Rockwell Automati
TWO Two Harbors Inves
EFX Equifax Inc. Com
Subscribe for the full list...
See below for more information on the markets:
NYSE
https://www.nyse.com/index
NASDAQ
http://www.nasdaq.com/
Test Drive the Markup Report today at
http://markupreport.com/subscribe/
(C) 2014 All Rights Reserved
http://youtu.be/DZBqkShtvfY
wn.com/Markupreport.Com Top Breakout Stocks 8 25 2014
Test Drive the Markup Report today at
http://markupreport.com/subscribe/
Ticker Name
DGLY Digital Ally Inc
ITMN InterMune Inc.
ADXS Advaxis Inc.
HGSH China HGS Real Es
BKW Burger King World
MOBL MobileIron Inc.
ATHM Autohome Inc. Ame
AXDX Accelerate Diagno
BITA Bitauto Holdings
ACHN Achillion Pharmac
CXDC China XD Plastics
CPRX Catalyst Pharmace
KANG iKang Healthcare
LRAD LRAD Corporation
SCLN SciClone Pharmace
KERX Keryx Biopharmace
RCPT Receptos Inc.
ROYT Pacific Coast Oil
CRNT Ceragon Networks
CLVS Clovis Oncology
ANN ANN INC. Common S
POZN Pozen Inc.
MNDO MIND C.T.I. Ltd.
VNET 21Vianet Group I
NKTR Nektar Therapeuti
GEVA Synageva BioPharm
AXAS Abraxas Petroleum
INCY Incyte Corporatio
WRES Warren Resources
EBIX Ebix Inc.
YGE Yingli Green Ener
PBR Petroleo Brasilei
MDVN Medivation Inc.
CONN Conn's Inc.
BIB ProShares Ultra N
JCP J.C. Penney Compa
PBR.A PBR.A
SM SM Energy Company
AVNR Avanir Pharmaceut
CCIH ChinaCache Intern
PTX Pernix Therapeuti
AMBA Ambarella Inc.
CBOE CBOE Holdings In
CLR Continental Resou
RPRX Repros Therapeuti
NEWM New Media Investm
CODE Spansion Inc Comm
IMMU Immunomedics Inc
NFX Newfield Explorat
ILMN Illumina Inc.
TPLM Triangle Petroleu
IMGN ImmunoGen Inc.
CENX Century Aluminum
BDSI BioDelivery Scien
IOC InterOil Corporat
ICLD InterCloud System
UVE UNIVERSAL INSURAN
WLL Whiting Petroleum
LKQ LKQ Corporation
ACOR Acorda Therapeuti
RRC Range Resources C
INFN Infinera Corporat
EOX Emerald Oil Inc.
PCRX Pacira Pharmaceut
BLDR Builders FirstSou
KOG Kodiak Oil & Gas
X United States Ste
ANAC Anacor Pharmaceut
CZZ Cosan Limited Cla
QRE QR Energy LP Com
FNHC Federated Nationa
ETE Energy Transfer E
DRTX Durata Therapeuti
LNG Cheniere Energy
IBB iShares Nasdaq Bi
CBST Cubist Pharmaceut
HRG Harbinger Group I
TRP TransCanada Corpo
GHL Greenhill & Co.
TXRH Texas Roadhouse
SERV ServiceMaster Glo
KNX Knight Transporta
BLK BlackRock Inc. C
LDRH LDR Holding Corpo
PBYI Puma Biotechnolog
SYRG Synergy Resources
PRTA Prothena Corporat
SNY Sanofi American D
CELG Celgene Corporati
CAM Cameron Internati
AKRX Akorn Inc.
ATHN athenahealth Inc
ITUB Itau Unibanco Ban
BCO Brinks Company (T
GLDD Great Lakes Dredg
PEP Pepsico Inc. Com
ASX Advanced Semicond
TAL TAL International
WWE World Wrestling E
OME Omega Protein Cor
ANDE The Andersons In
PTRY The Pantry Inc.
KKD Krispy Kreme Doug
CAMP CalAmp Corp.
CPL CPFL Energia S.A.
IRDM Iridium Communica
CAKE The Cheesecake Fa
BBEP BreitBurn Energy
ACMP Access Midstream
TCPC TCP Capital Corp.
NDAQ The NASDAQ OMX Gr
NMBL Nimble Storage I
WETF WisdomTree Invest
SPXL Direxion Daily S&
HCBK Hudson City Banco
SKM SK Telecom Co. L
CX Cemex S.A.B. de
WLK Westlake Chemical
UPRO ProShares UltraPr
ENR Energizer Holding
AMGN Amgen Inc.
CLB Core Laboratories
SGEN Seattle Genetics
UBNT Ubiquiti Networks
JPM JP Morgan Chase &
UPL Ultra Petroleum C
BUD Anheuser-Busch In
DEPO Depomed Inc.
UGP Ultrapar Particip
NSM Nationstar Mortga
ERII Energy Recovery
MBT Mobile TeleSystem
JBL Jabil Circuit In
EEP Enbridge Energy
CBI Chicago Bridge &
JAZZ Jazz Pharmaceutic
TNA Direxion Small Ca
CNO CNO Financial Gro
FV First Trust Dorse
ECA Encana Corporatio
YELP Yelp Inc. Class A
ODFL Old Dominion Frei
ACM Aecom Technology
CS Credit Suisse Gro
ABBV AbbVie Inc. Commo
HLSS Home Loan Servici
CHKP Check Point Softw
CTL CenturyLink Inc.
GPRE Green Plains Inc
TK Teekay Corporatio
EL Estee Lauder Comp
ING ING Group N.V. C
L Loews Corporation
SIG Signet Jewelers L
ALL Allstate Corporat
AZN Astrazeneca PLC C
PNW Pinnacle West Cap
CSIQ Canadian Solar In
ORI Old Republic Inte
AXS Axis Capital Hold
BLOX Infoblox Inc. Com
SWHC Smith & Wesson Ho
HIG Hartford Financia
DFS Discover Financia
CE Celanese Corporat
SSO ProShares Ultra S
WIBC Wilshire Bancorp
XIV Credit Suisse AG
BMRN BioMarin Pharmace
STRZA Starz
GWW W.W. Grainger In
BID Sotheby's Common
AIG American Internat
ORLY O'Reilly Automoti
FSLR First Solar Inc.
PFG Principal Financi
ASNA Ascena Retail Gro
RYN Rayonier Inc. REI
SYK Stryker Corporati
SVXY ProShares Short V
MRK Merck & Company
LULU lululemon athleti
PSX Phillips 66 Commo
NMFC New Mountain Fina
CRL Charles River Lab
MOH Molina Healthcare
MRO Marathon Oil Corp
WYN Wyndham Worldwide
NKE Nike Inc. Common
XL XL Group plc
CPRT Copart Inc.
WDR Waddell & Reed Fi
AMCX AMC Networks Inc.
CQB Chiquita Brands I
RGA Reinsurance Group
FII Federated Investo
PNNT PennantPark Inves
IBKR Interactive Broke
GRA W.R. Grace & Co.
VWO Vanguard FTSE Eme
KAR KAR Auction Servi
D Dominion Resource
AGIO Agios Pharmaceuti
PPG PPG Industries I
VC Visteon Corporati
LNCO Linn Co LLC
ECL Ecolab Inc. Commo
SBY Silver Bay Realty
NOV National Oilwell
MSM MSC Industrial Di
TGI Triumph Group In
ROK Rockwell Automati
TWO Two Harbors Inves
EFX Equifax Inc. Com
Subscribe for the full list...
See below for more information on the markets:
NYSE
https://www.nyse.com/index
NASDAQ
http://www.nasdaq.com/
Test Drive the Markup Report today at
http://markupreport.com/subscribe/
(C) 2014 All Rights Reserved
http://youtu.be/DZBqkShtvfY
- published: 03 Sep 2014
- views: 18
-
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John RothmanProphylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
Subscribe: http://www.youtube.com/user/vaccinenation Dr John Rothman from Advaxis joined us at the World Vaccine Congress to present details about Microbial ... -
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
Host Damon Roberts continues his Biotech Week news and views blitz with special month- long guest John McCamant, editor of the Medical Technology Stock Letter (MTSL). Together, Roberts and McCamant hold a video sit-down with Dr. Pnina Fishman, CEO of Can-Fite BioPharma, Ltd. (NYSE:CANF). Roberts and McCamant discuss the importance of January in biotech, from of San Francisco Biotech Week to the optimism of the "January effect," as well as the effectiveness of FDA regulation in the biotech industry and the value of acquiring small cap companies to bolster the development pipelines and strengthen the portfolios of the key players in the biotec -
Northwest Bio Presents at Phacilitate Immunotherapy World 2015
Northwest Bio Presents at Phacilitate Immunotherapy World 2015Northwest Bio Presents at Phacilitate Immunotherapy World 2015
January 26, 2015 - Washington, DC - The CEO of Northwest Biotherapeutics speaks on the topic of "Personalized Approaches to Immune Therapy." -
Panel discussion: Wall Street perspectives on the field of immunotherapy
Panel discussion: Wall Street perspectives on the field of immunotherapyPanel discussion: Wall Street perspectives on the field of immunotherapy
Panel discussion "Wall Street perspectives on the field of immunotherapy" moderated by Joseph Pantginis, Ph.D., of ROTH Capital Partners, from MD Becker Part... -
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry BoxerWEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
Each Wednesday evening at 7:30 PM Eastern Time, TradersCoach.com® will host industry leading speakers on trading the financial markets, we call this ongoing ... -
Episode 9 − Health Claims: Uncut conversation with Ian Frazer
Episode 9 − Health Claims: Uncut conversation with Ian FrazerEpisode 9 − Health Claims: Uncut conversation with Ian Frazer
We've seen that what we perceive and remember is literally shaped by our experiences and expectations. The placebo effect is another example of this phenomen...
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
- Order: Reorder
- Duration: 24:54
- Updated: 01 Feb 2014
- author: Vaccine Nation
Subscribe: http://www.youtube.com/user/vaccinenation Dr John Rothman from Advaxis joined us at the World Vaccine Congress to present details about Microbial ...
wn.com/Prophylactic Vaccines Microbial Active Immuno Therapy (Mait) Dr John Rothman
Subscribe: http://www.youtube.com/user/vaccinenation Dr John Rothman from Advaxis joined us at the World Vaccine Congress to present details about Microbial ...
- published: 21 Oct 2011
- views: 970
- author: Vaccine Nation
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
- Order: Reorder
- Duration: 29:44
- Updated: 14 Jan 2015
Host Damon Roberts continues his Biotech Week news and views blitz with special month-
long guest John McCamant, editor of the Medical Technology Stock Letter (MTSL). Together, Roberts and McCamant hold a video sit-down with Dr. Pnina Fishman, CEO of Can-Fite BioPharma, Ltd. (NYSE:CANF).
Roberts and McCamant discuss the importance of January in biotech, from of San Francisco Biotech Week to the optimism of the "January effect," as well as the effectiveness of FDA regulation in the biotech industry and the value of acquiring small cap companies to bolster the development pipelines and strengthen the portfolios of the key players in the biotech sector.
Dr. Pnina Fishman discusses her own history in biotech as well as the history of Can-Fite Biopharma, it's current pipeline, and its future prospects.
Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
The show is shot in-studio in New York, and is hosted by Mr. Damon Roberts, who has anchored the WWOS programming since 2009.
One segment in each broadcast features an interview with analysts, portfolio managers, CEO or other market participants. The show also incorporates remote interview feeds.
Wide World of Stocks will be seen everyday in 50+ million homes, distributed daily over the BizTV, BizTalk Radio & YouToo America Platform.
Content is further marketed over social media platforms including YouTube, Twitter, Facebook, LinkedIn and other industry specific platforms. Content also simultaneously distributed to an additional 5 million opt-in market participants through our integrated network of joint venture partners including StockWatchIndex and NYSE Post.
wn.com/Biotech Blitz 2015 January 13, 2015 Can Fite Biopharma (Nyse Canf)
Host Damon Roberts continues his Biotech Week news and views blitz with special month-
long guest John McCamant, editor of the Medical Technology Stock Letter (MTSL). Together, Roberts and McCamant hold a video sit-down with Dr. Pnina Fishman, CEO of Can-Fite BioPharma, Ltd. (NYSE:CANF).
Roberts and McCamant discuss the importance of January in biotech, from of San Francisco Biotech Week to the optimism of the "January effect," as well as the effectiveness of FDA regulation in the biotech industry and the value of acquiring small cap companies to bolster the development pipelines and strengthen the portfolios of the key players in the biotech sector.
Dr. Pnina Fishman discusses her own history in biotech as well as the history of Can-Fite Biopharma, it's current pipeline, and its future prospects.
Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
The show is shot in-studio in New York, and is hosted by Mr. Damon Roberts, who has anchored the WWOS programming since 2009.
One segment in each broadcast features an interview with analysts, portfolio managers, CEO or other market participants. The show also incorporates remote interview feeds.
Wide World of Stocks will be seen everyday in 50+ million homes, distributed daily over the BizTV, BizTalk Radio & YouToo America Platform.
Content is further marketed over social media platforms including YouTube, Twitter, Facebook, LinkedIn and other industry specific platforms. Content also simultaneously distributed to an additional 5 million opt-in market participants through our integrated network of joint venture partners including StockWatchIndex and NYSE Post.
- published: 14 Jan 2015
- views: 2947
Northwest Bio Presents at Phacilitate Immunotherapy World 2015
- Order: Reorder
- Duration: 23:01
- Updated: 03 Feb 2015
January 26, 2015 - Washington, DC - The CEO of Northwest Biotherapeutics speaks on the topic of "Personalized Approaches to Immune Therapy."
wn.com/Northwest Bio Presents At Phacilitate Immunotherapy World 2015
January 26, 2015 - Washington, DC - The CEO of Northwest Biotherapeutics speaks on the topic of "Personalized Approaches to Immune Therapy."
- published: 03 Feb 2015
- views: 9
Panel discussion: Wall Street perspectives on the field of immunotherapy
- Order: Reorder
- Duration: 57:20
- Updated: 04 Sep 2013
- author: Michael Becker
Panel discussion "Wall Street perspectives on the field of immunotherapy" moderated by Joseph Pantginis, Ph.D., of ROTH Capital Partners, from MD Becker Part...
wn.com/Panel Discussion Wall Street Perspectives On The Field Of Immunotherapy
Panel discussion "Wall Street perspectives on the field of immunotherapy" moderated by Joseph Pantginis, Ph.D., of ROTH Capital Partners, from MD Becker Part...
- published: 29 Nov 2011
- views: 372
- author: Michael Becker
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
- Order: Reorder
- Duration: 60:43
- Updated: 08 Feb 2014
- author: traderscoach
Each Wednesday evening at 7:30 PM Eastern Time, TradersCoach.com® will host industry leading speakers on trading the financial markets, we call this ongoing ...
wn.com/Wednesday Night Live (Wnl) Featuring Harry Boxer
Each Wednesday evening at 7:30 PM Eastern Time, TradersCoach.com® will host industry leading speakers on trading the financial markets, we call this ongoing ...
- published: 06 Feb 2014
- views: 174
- author: traderscoach
Episode 9 − Health Claims: Uncut conversation with Ian Frazer
We've seen that what we perceive and remember is literally shaped by our experiences and expectations. The placebo effect is another example of this phenomen...
wn.com/Episode 9 − Health Claims Uncut Conversation With Ian Frazer
We've seen that what we perceive and remember is literally shaped by our experiences and expectations. The placebo effect is another example of this phenomen...
- published: 04 May 2014
- views: 702
- author: Think101
close fullscreen
- Playlist
- Chat
close
close fullscreen
- Playlist
- Chat
7:00
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
SNNLive spoke with Thomas Moore, Chairman and CEO of Advaxis, Inc. (ADXS:OTCBB) at the 201...
published: 25 Jan 2013
author: Stock News Now
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
SNNLive with Advaxis, Inc.: Update on Clinical Trial for Cervical Cancer
- published: 25 Jan 2013
- views: 314
-
author:
Stock News Now
Add Playlist for this Author
4:44
**Video Chart** -- $ADXS Advaxis Inc
This is a video chart analysis of Advaxis (ADXS) as of April 12th, 2015...
published: 12 Apr 2015
**Video Chart** -- $ADXS Advaxis Inc
**Video Chart** -- $ADXS Advaxis Inc
- published: 12 Apr 2015
- views: 64
6:06
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
After a climb from 10 cents that reached a peak at nearly 20 cents, the ADXS chart has ret...
published: 15 Dec 2010
author: AllPennyStocks
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
Advaxis, Inc. (ADXS.OB) Annotated Stock Chart
- published: 15 Dec 2010
- views: 282
-
author:
AllPennyStocks
Add Playlist for this Author
1:47
Adaxis's Trojan Horse Technology™
Advaxis is developing multiple cancer immunotherapies based on our proprietary platform in...
published: 06 Oct 2014
Adaxis's Trojan Horse Technology™
Adaxis's Trojan Horse Technology™
- published: 06 Oct 2014
- views: 114
10:39
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
4/14/15 - https://www.thetechtrader.com - Even though the markets were mixed on Tuesday, a...
published: 15 Apr 2015
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
ADXS, CAPN, OAS, TSEM - Harry Boxer Charts to Watch
- published: 15 Apr 2015
- views: 88
3:39
Advaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis ADXS-HPV is selected as the "Best Therapeutic Vaccine" at the 2012 World Vaccine C...
published: 12 Apr 2012
author: Rg Petit
Advaxis receives 2012 VIE award for best therapeutic vaccine
Advaxis receives 2012 VIE award for best therapeutic vaccine
- published: 12 Apr 2012
- views: 644
-
author:
Rg Petit
Add Playlist for this Author
18:41
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
...
published: 16 Apr 2015
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
【Episode 10】Can We Beat Down Cancer Someday?!! 【创美10】 Advaxis:免疫疗法引领癌症治疗新革命
- published: 16 Apr 2015
- views: 50
7:40
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
9/15/15 - www.TheTechTrader.com - It was a very good day on Wall Street on Tuesday. The ma...
published: 15 Sep 2015
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
ACET, ADXS, ITEK, SCMP - Harry Boxer, TheTechTrader.com
- published: 15 Sep 2015
- views: 15
1:29
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Cash Flow from Operations for Advaxis, Inc. for its quarter ended January 31st was minus $...
published: 23 Apr 2011
author: Stocktrendnews
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
Advaxis CFFO Off 152%- Global Financial News Minute with Donald Baillargeon
- published: 23 Apr 2011
- views: 176
-
author:
Stocktrendnews
Add Playlist for this Author
6:39
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
03/31/15 - http//www.TheTechTrader.com - The markets did not have a good day on this turna...
published: 01 Apr 2015
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
ADXS, CAPN, ELOS, ONCE – Stock Charts - Harry Boxer, TheTechTrader.com
- published: 01 Apr 2015
- views: 13
2:57
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
Advaxis has seen its shares surge higher in the past month due to increased institutional ...
published: 15 Jan 2015
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
Soaring Immunotherapy Interest Pushing Advaxis Shares Higher
- published: 15 Jan 2015
- views: 34
2:12
Advaxis: CEO Dan O'Connor
Dan O'Connor, President and CEO of Advaxis, discusses his company's near term and long ter...
published: 12 Feb 2014
author: Executive Video
Advaxis: CEO Dan O'Connor
Advaxis: CEO Dan O'Connor
- published: 12 Feb 2014
- views: 137
-
author:
Executive Video
Add Playlist for this Author
4:13
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Drs. Marc Siegel and David Samadi discuss Advaxis's cancer immunotherapy as a potential tr...
published: 30 Dec 2014
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
Fox News’ Sunday Housecall - Experimental treatment uses immune system to fight cancer
- published: 30 Dec 2014
- views: 7
18:41
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Tom Moore, Chairman and CEO of Advaxis, discusses the company's business model, immunother...
published: 20 Feb 2013
author: QualityStocks
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
Advaxis, Inc. (ADXS) Chairman and CEO Interviewed by SmallCapVoice
- published: 20 Feb 2013
- views: 113
-
author:
QualityStocks
Add Playlist for this Author
close
close fullscreen
- Playlist
- Chat
2:30
MarkupReport.com Top Breakout Stocks 8-25-2014
Test Drive the Markup Report today at
http://markupreport.com/subscribe/
Ticker Name
...
published: 03 Sep 2014
MarkupReport.com Top Breakout Stocks 8-25-2014
MarkupReport.com Top Breakout Stocks 8-25-2014
- published: 03 Sep 2014
- views: 18
close
close fullscreen
- Playlist
- Chat
24:54
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
Subscribe: http://www.youtube.com/user/vaccinenation Dr John Rothman from Advaxis joined u...
published: 21 Oct 2011
author: Vaccine Nation
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
Prophylactic vaccines: Microbial Active Immuno-Therapy (MAIT)- Dr John Rothman
- published: 21 Oct 2011
- views: 970
-
author:
Vaccine Nation
Add Playlist for this Author
29:44
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
Host Damon Roberts continues his Biotech Week news and views blitz with special month-
lon...
published: 14 Jan 2015
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
BioTech Blitz 2015 - January 13, 2015 - Can-Fite BioPharma (NYSE: CANF)
- published: 14 Jan 2015
- views: 2947
23:01
Northwest Bio Presents at Phacilitate Immunotherapy World 2015
January 26, 2015 - Washington, DC - The CEO of Northwest Biotherapeutics speaks on the top...
published: 03 Feb 2015
Northwest Bio Presents at Phacilitate Immunotherapy World 2015
Northwest Bio Presents at Phacilitate Immunotherapy World 2015
- published: 03 Feb 2015
- views: 9
57:20
Panel discussion: Wall Street perspectives on the field of immunotherapy
Panel discussion "Wall Street perspectives on the field of immunotherapy" moderated by Jos...
published: 29 Nov 2011
author: Michael Becker
Panel discussion: Wall Street perspectives on the field of immunotherapy
Panel discussion: Wall Street perspectives on the field of immunotherapy
- published: 29 Nov 2011
- views: 372
-
author:
Michael Becker
Add Playlist for this Author
60:43
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
Each Wednesday evening at 7:30 PM Eastern Time, TradersCoach.com® will host industry leadi...
published: 06 Feb 2014
author: traderscoach
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer
- published: 06 Feb 2014
- views: 174
-
author:
traderscoach
Add Playlist for this Author
22:37
Episode 9 − Health Claims: Uncut conversation with Ian Frazer
We've seen that what we perceive and remember is literally shaped by our experiences and e...
published: 04 May 2014
author: Think101
Episode 9 − Health Claims: Uncut conversation with Ian Frazer
Episode 9 − Health Claims: Uncut conversation with Ian Frazer
- published: 04 May 2014
- views: 702
-
author:
Think101
Add Playlist for this Author
close
Prophylactic vaccines: Microbial Active Immuno-The...
BioTech Blitz 2015 - January 13, 2015 - Can-Fite B...
Northwest Bio Presents at Phacilitate Immunotherap...
Panel discussion: Wall Street perspectives on the ...
WEDNESDAY NIGHT LIVE (WNL): Featuring Harry Boxer...
Episode 9 − Health Claims: Uncut conversation with...
photo: US Navy / John F. Williams
The rise of the killer robots -- and why we need to stop them
Edit CNN 26 Oct 2015
(CNN)Lethal autonomous weapons (or as the media like to call them, "killer robots") were back on the agenda at the U.N. last week. The Campaign to Stop Killer Robots launched in 2013, and pleasingly the issue was quickly taken up by the U.N. Convention on Certain Conventional Weapons (CCW) in Geneva ... Here's five of them. 1. Killer robots are near ... This is technically possible today. Professor Toby Walsh. 2. There will be an arms race ... 3 ... 4 ... 5 ... ....
photo: AP / Ammar El-Darwish, File
Apex of Western Hypocrisy Is Executing Seif al-Islam Gaddafi
Edit WorldNews.com 26 Oct 2015
Article by WN.com Correspondent Dallas Darling. When a congressional aide asked Seif al-Islam Gaddafi what Libya needed, his one-word answer was “democracy.” Sitting in a black cage in a Libyan prison and awaiting execution –death by firing squad – Seif al-Islam, second son of late Libyan leader Muammar Gaddafi, is still in search of democracy ... Seif al-Islam, however, knows all about democracy and justice ... (1) www.wikipedia.com ... 222. ....
photo: AP / Channi Anand
Powerful Earthquake Hits Afghanistan, India, Pakistan
Edit Huffington Post 26 Oct 2015
KABUL, Oct 26 (Reuters) - A major earthquake struck northeastern Afghanistan on Monday, the U.S. Geological Survey said, shaking the capital Kabul and sending shockwaves that were felt in north India and Pakistan, where officials said four people had been killed ... Buildings shook for well over a minute in the Indian capital, New Delhi, sending office workers scurrying onto the streets ... ....
photo: Public Domain
Bacon, sausage and other processed meats do cause cancer – WHO
Edit The Miami Herald 26 Oct 2015
A research division of the World Health Organization announced on Monday that bacon, sausage and other processed meats cause cancer, and that red meat probably does, too. The report by the influential group stakes out one of the most aggressive stances against meat yet taken by a major health organization, and it is expected to face stiff criticism in the United States ... The $95 billion U.S ... cancer-who ....
photo: AP / Abdeljalil Bounhar
Morocco poised to become a solar superpower with launch of desert mega-project
Edit The Guardian 26 Oct 2015
World’s largest concentrated solar power plant, powered by the Saharan sun, set to help renewables provide almost half the country’s energy by 2020. The Moroccan city of Ouarzazate is used to big productions ... The project is a key plank in Morocco’s ambitions to use its untapped deserts to become a global solar superpower. Twitter ... The potential for solar power from the desert has been known for decades ... Campaign sign up ... Twitter ... Twitter ... ....
« back to news headlines
PDC Energy Announces CFO Gysle Shellum to Retire in 2016 (PDC Energy Inc)
Edit Public Technologies 27 Oct 2015
(Source. PDC Energy Inc). October 26, 2015. DENVER, October 26, 2015 (GLOBE NEWSWIRE) -- PDC Energy, Inc. ('PDC', the 'Company,' 'we' or 'us') (NASDAQ.PDCE) today announced that. Gysle Shellum, Chief Financial Officer ('CFO'), will retire from the Company effective June 30, 2016. Mr. Shellum joined the Company in 2008 and has served as CFO since that time ... About PDC Energy, Inc. PDC Energy, Inc ... This content was issued by PDC Energy Inc....
Oasis Petroleum Inc. Announces Successful Completion Of Its Consent Solicitations (Oasis Petroleum Inc)
Edit Public Technologies 27 Oct 2015
(Source. Oasis Petroleum Inc). HOUSTON, Oct. 26, 2015/PRNewswire / -- Oasis Petroleum Inc. (NYSE ... 67415AC2), 6.5% Senior Notes due 2021 (CUSIP No. 674215AD0) and 6.875% Senior Notes due 2023 (CUSIP No ... F. King& Co., Inc ... About Oasis Petroleum Inc ... SOURCE Oasis Petroleum Inc ... Oasis Petroleum Inc., Richard Robuck, (281) 404-9600, Vice President, Finance & Treasurer distributed by. This content was issued by Oasis Petroleum Inc ... (noodl. 30520559) ....
Publix Issues Voluntary Recall for German Chocolate Layer Cake (Publix Super Markets Inc)
Edit Public Technologies 27 Oct 2015
(Source. Publix Super Markets Inc). LAKELAND, FLA., October 26, 2015 - Out of an abundance of caution, Publix Super Markets, Inc. is issuing a voluntary recall for Publix German Chocolate Layer Cake ... distributed by. This content was issued by Publix Super Markets Inc ... (noodl. 30520647) ....
Rambus Initiates Accelerated Share Repurchase Program (Rambus Inc)
Edit Public Technologies 27 Oct 2015
(Source. Rambus Inc). SUNNYVALE, Calif.--(BUSINESS WIRE)-- Rambus Inc. (NASDAQ.RMBS) today announced it has initiated an accelerated share repurchase program with Citibank, N.A. to repurchase an aggregate of approximately $100 million of its common stock, with an initial delivery of approximately 7,812,500 shares ... Ron Black, president and chief executive officer at Rambus ... About Rambus Inc ... Rambus Inc ... This content was issued by Rambus Inc....
Oasis Petroleum Inc. Announces Successful Completion Of Its Consent Solicitations
Edit Stockhouse 27 Oct 2015
HOUSTON, Oct. 26, 2015 /PRNewswire/ -- Oasis Petroleum Inc. (NYSE ... 67415AC2), 6.5% Senior Notes due 2021 (CUSIP No. 674215AD0) and 6.875% Senior Notes due 2023 (CUSIP No ... F. King & Co., Inc ... About Oasis Petroleum Inc ... To view the original version on PR Newswire, visit.http.//www.prnewswire.com/news-releases/oasis-petroleum-inc-announces-successful-completion-of-its-consent-solicitations-300166457.html. SOURCE Oasis Petroleum Inc. ....
Halloween Disco - Family Event tickets
Edit Skiddle 27 Oct 2015
The Venue in Dudley. Friday 30th October 2015. 8.30pm til 1.00am (last entry 11.00pm). No age restrictions. Halloween Disco - Family Event. Event Info ... + £1.00 bf inc bf 01234567891011121314151617181920 Advance Discount Ticket - Ticket Only - CHILD - £3.50 ... + £1.00 bf inc bf 01234567891011121314151617181920 Advance Discount Ticket - Ticket Only - Baby - £0.00 ... + £0.00 bf inc bf 01234567891011121314151617181920 ... ....
Habitat for Humanity of Greater Greensboro and Columbia Forest Products Host Inaugural Summer Bash: One ...
Edit Public Technologies 27 Oct 2015
(Source. Columbia Forest Products Inc). Presenting Sponsor, Columbia Forest Products, together with Habitat for Humanity of Greater Greensboro and many other event sponsors, hosted the inaugural Summer Bash. One Night … One House at Summerfield Farms on August 28, 2015 ... distributed by. This content was issued by Columbia Forest Products Inc ... (noodl. 30520537) ....
Why Zooey Deschanel's media startup HelloGiggles sold to Time
Edit Siliconvalley online 27 Oct 2015
Los Angeles media startup HelloGiggles, co-founded by actress Zooey Deschanel, has sold to Time Inc ... ....
UPDATE 4-Yahoo's NFL debut bodes well for game streaming -media buyers
Edit Reuters 27 Oct 2015
Oct 26 (Reuters) - The reach of Yahoo Inc's first global live-stream of a National Football League game on Sunday is likely to result in the league striking future deals with online distributors, media buyers said on Monday. ....
TIMELINE-Deals, and doubts, mark Valeant's acquisition history
Edit Reuters 27 Oct 2015
Oct 26 (Reuters) - Valeant Pharmaceuticals International Inc laid out a defense of its relationship with a specialty pharmacy on Monday, but failed to dispel all investor concerns. ....
UQM Technologies Signs Ten Year Supply Agreement With Chinese Customer (UQM Technologies Inc)
Edit Public Technologies 27 Oct 2015
(Source. UQM Technologies Inc). UQM Technologies Inc. (NYSE MKT. UQM) today announced the signing of a ten year supply agreement ('Agreement') with ITL Efficiency Corporation ('ITL') in China, a subsidiary of Eastlake New Energy ('Eastlake'). Over the term of the Agreement, revenues could exceed $400 million based on projected volume shipments ... Mr ... Conference Call ... Eastern Time tomorrow ... This content was issued by UQM Technologies Inc ... (noodl....
Traphouse Taster Sessions £1 Entry Tickets tickets
Edit Skiddle 27 Oct 2015
FAC 251 The Factory in Manchester. Tuesday 27th October 2015. 11.00pm til 4.00am (last entry 1.00am). Minimum Age. 18. Traphouse Taster Sessions £1 Entry Tickets. Event Info. Venue ... + £1.00 bf inc bf 012345678. Embed Ticket Box....
Concrete Halloween. With Applebottom tickets
Edit Skiddle 27 Oct 2015
Phonox in London. Tuesday 27th October 2015. 10.00pm til 3.00am. Minimum Age. 18. Concrete Halloween at Phonox. Expect a spectacularly spooky party for week 3 at Phonox. This week we have Applebottom. Event Info. Venue. Buy tickets securely ... + £1.00 bf inc bf 012345678....
- 1
- 2
- 3
- 4
- 5
- Next page »
×
Share this video with your family and friends
